EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 29 / No 6-7 (Juin–Juillet 2013) Med Sci (Paris), 29 6-7 (2013) 574-576 References
Free Access
Issue
Med Sci (Paris)
Volume 29, Number 6-7, Juin–Juillet 2013
Page(s) 574 - 576
Section Nouvelles
DOI https://doi.org/10.1051/medsci/2013296007
Published online 12 July 2013
  1. Landgraf P, Rusu M, Sheridan R, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007 ; 129 : 1401–1414. [CrossRef] [PubMed] [Google Scholar]
  2. Mildner A, Chapnik E, Manor O, et al. Mononuclear phagocyte miRNome analysis identifies miR-142 as critical regulator of murine dendritic cell homeostasis. Blood 2013 ; 121 : 1016–1027. [CrossRef] [PubMed] [Google Scholar]
  3. Nishiyama T, Kaneda R, Ono T, et al. miR-142-3p is essential for hematopoiesis and affects cardiac cell fate in zebrafish. Biochem Biophys Res Commun 2012 ; 425 : 755–761. [CrossRef] [PubMed] [Google Scholar]
  4. Esquela-Kerscher A, Slack FJ. Oncomirs – microRNAs with a role in cancer. Nat Rev Cancer 2006 ; 6 : 259–269. [CrossRef] [PubMed] [Google Scholar]
  5. Zhao JJ, Lin J, Lwin T, et al. microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Blood 2010 ; 115 : 2630–2639. [CrossRef] [PubMed] [Google Scholar]
  6. Lv M, Zhang X, Jia H, et al. An oncogenic role of miR-142–3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-alpha and cAMP/PKA pathways. leukemia 2012 ; 26 : 769–777. [CrossRef] [PubMed] [Google Scholar]
  7. Wang XS, Gong JN, Yu J, et al. MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia. Blood 2012 ; 119 : 4992–5004. [CrossRef] [PubMed] [Google Scholar]
  8. Lagrange B, Martin RZ, Droin N, et al. A role for miR-142-3p in colony-stimulating factor 1-induced monocyte differentiation into macrophages. Biochim Biophys Acta 2013 ; 1833 : 1936–1946. [CrossRef] [PubMed] [Google Scholar]
  9. Itzykson R, Kosmider O, Renneville A, et al. A prognostic score accounting for molecular lesions in chronic myelomonocytic leukemias. J Clin Oncol 2013 (sous presse). [Google Scholar]
  10. Flamant S, Ritchie W, Guilhot J, et al. Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia. Haematologica 2010 ; 95 : 1325–1333. [CrossRef] [PubMed] [Google Scholar]
  11. Venturini L, Battmer K, Castoldi M, et al. Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood 2007 ; 109 : 4399–4405. [CrossRef] [PubMed] [Google Scholar]
  12. Dunoyer P. La bataille du silence : mécanisme et inhibition du RNA silencing au cours des interactions plante/virus. Med Sci (Paris) 2009 ; 25 : 505–512. [Google Scholar]
  13. Bousquet M, Dastugue N, Brousset P. MicroARN et translocations chromosomiques dans les hémopathies malignes. Med Sci (Paris) 2009 ; 25 : 229–231. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.